ORAMED PHARMACEUTICALS INC.(ORMP)内部人交易:高管与董事近期交易
过去 18 个月,共有 9 位内部人为 ORAMED PHARMACEUTICALS INC.(ORMP)报告了 66 笔 Form 4 交易(最近一笔 2026-11-13)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-13 | Shapiro Benjamin | 董事 | 买入 | 1,050 | $0 |
| 2026-11-13 | Reznick Yehuda | 董事 | 买入 | 2,890 | $0 |
| 2026-11-13 | Hexter Joshua | COO & CBO | 买入 | 357,000 | $0 |
| 2026-11-13 | Gabay Avraham | Chief Financial Officer | 买入 | 357,000 | $0 |
| 2026-11-13 | Mayer Arie | 董事 | 买入 | 72,780 | $0 |
| 2026-11-13 | Shapiro Benjamin | 董事 | 买入 | 72,780 | $0 |
| 2026-11-13 | Aghion Daniel | 董事 | 买入 | 72,780 | $0 |
| 2026-11-13 | Kidron Miriam | Chief Scientific Officer | 买入 | 357,000 | $0 |
| 2026-11-13 | KIDRON NADAV | President and CEO | 买入 | 688,000 | $0 |
| 2026-11-13 | Kidron Miriam | Chief Scientific Officer | 买入 | 242,000 | $0 |
| 2026-11-13 | Hexter Joshua | COO & CBO | 买入 | 242,000 | $0 |
| 2026-11-13 | Gabay Avraham | Chief Financial Officer | 买入 | 242,000 | $0 |
| 2026-11-13 | Mayer Arie | 董事 | 买入 | 1,470 | $0 |
| 2026-11-13 | KIDRON NADAV | President and CEO | 买入 | 629,000 | $0 |
| 2026-11-13 | Aghion Daniel | 董事 | 买入 | 2,890 | $0 |
| 2026-11-13 | Reznick Yehuda | 董事 | 买入 | 72,780 | $0 |
| 2026-10-02 | Hexter Joshua | COO & CBO | 卖出 | 30,000 | $135,330 |
| 2026-10-02 | Gabay Avraham | Chief Financial Officer | 卖出 | 20,000 | $90,200 |
| 2026-09-25 | Gabay Avraham | Chief Financial Officer | 买入 | 209,291 | $0 |
| 2026-09-25 | KIDRON NADAV | President and CEO | 买入 | 368,765 | $0 |
| 2026-09-25 | Hexter Joshua | COO & CBO | 买入 | 209,291 | $0 |
| 2026-09-25 | Kidron Miriam | Chief Scientific Officer | 买入 | 208,125 | $0 |
| 2026-09-25 | Kidron Miriam | Chief Scientific Officer | 买入 | 209,291 | $0 |
| 2026-09-25 | KIDRON NADAV | President and CEO | 买入 | 349,497 | $0 |
| 2026-09-25 | Hexter Joshua | COO & CBO | 买入 | 75,455 | $0 |
来源:SEC Form 4 申报文件 · 截至 2026-11-13